Acquisition Growth The recent acquisition of ILS Automation by DCI Inc. indicates potential for expanded product integration and cross-selling opportunities within DCI's existing client base, especially in bioprocessing and automation sectors.

Industry Recognition Receiving the gold Ignition Firebrand Award demonstrates ILS's strong industry reputation and technological expertise, which can be leveraged to target organizations seeking reputable automation solutions with proven innovation credentials.

Specialized Bioprocess Technologies ILS's development of custom bioreactor control systems like AFC 928 offers a tailored solution for biotech firms and research laboratories, presenting opportunities to expand into biopharmaceutical manufacturing and laboratory automation markets.

Strategic Software Integration Their expertise in integrating laboratory control systems with SCADA software such as Ignition positions ILS well to serve clients looking for seamless, customized automation and control solutions across process industries.

Growth Potential With a revenue range of one to ten million dollars and a niche focus on process automation, ILS offers an accessible entry point for large industrial companies seeking specialized, flexible automation partners for expansion into chemical, biotech, and refining sectors.